Admission Date:  [**2159-12-29**]              Discharge Date:   [**2160-1-6**]  Date of Birth:  [**2090-1-18**]             Sex:   F  Service: MEDICINE  Allergies: Losartan / Aspirin / Lisinopril-Hctz  Attending:[**First Name3 (LF) 398**] Chief Complaint: fever, hypotension  Major Surgical or Invasive Procedure: trans-esophageal echocardiogram   History of Present Illness: 69F with h/o ESRD on HD, PE (PEA arrest), recent admit for sepsis of unclear etiology from [**Date range (2) 4167**], presenting to ED with fever Tm 102, hypotension, decreased appetite and lethargy per son.
Pt has had loose stools x 2 in the past few days with hypomagnesemia and hypophosphatemia receiving PO repletion w/o benefit.
Pt received empiric Abx coverage of Vanc/Cefepime/Levaquin/Flagyl at [**Hospital **] Rehab prior to transfer.
Recent hospitalization notable for intubation for airway protection in setting of obtundation, no clear source of infection.
Micro data remarkable for yeast and VRE in urine for which pt received 7d Fluconazole and 14d course of Linezolid (LD [**2159-12-27**]).
Also failed [**Last Name (un) **] stim and was on stress dosed steroids.
PICC removed and tunneled HD catheter changed over wire on [**2159-12-18**] (from [**10-15**]).
A new PICC was inserted prior to discharge on [**12-18**].
Diabetic nephropathy resulting in ESRD for which she is on HD Mon, Wed, and Fri. 3.
Status post left femur fracture 4.
S/P L shoulder hemiarthroplasty following a left humeral fracuture in [**10/2159**]- Course was complicated by a PEA arrest secondary to PE.
Hospitalization [**11-24**] for Sepsis (negative work-up) treated empricially with Vanc 14. h/o C-diff [**2159-11-22**], Urine citrobacter (tx w/Cipro)   Social History: Lives with son who is very involved and well informed regarding her care needs.
Toes down-going BACK:minimal skin breakdown new buttocks.
Consider Infectious          Disease consultation for serious infections caused by          ESBL-producing E. coli and Klebsiella species.
10,000-100,000 ORGANISMS/ML..                                SENSITIVITIES: MIC expressed in MCG/ML  _________________________________________________________                              KLEBSIELLA PNEUMONIAE                              |          PSEUDOMONAS AERUGINOSA                              |          | AMPICILLIN/SULBACTAM--    16 I CEFAZOLIN-------------  =>64 R CEFEPIME--------------       R        8 S CEFTAZIDIME-----------  =>64 R        4 S CEFTRIAXONE-----------       R CEFUROXIME------------    32 R CIPROFLOXACIN---------   =>4 R      =>4 R GENTAMICIN------------   <=1 S     =>16 R IMIPENEM--------------   <=1 S        4 S LEVOFLOXACIN----------   =>8 R MEROPENEM-------------<=0.25 S   <=0.25 S NITROFURANTOIN--------    64 I PIPERACILLIN----------                8 S PIPERACILLIN/TAZO-----     8 S      <=4 S TOBRAMYCIN------------  =>16 R     =>16 R TRIMETHOPRIM/SULFA----   <=1 S .
5.The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present.
Wounds and osteomyelitis were also considered as possibilities, but her surgical wound from past ortho procedure was clean and did not appear infected.
A new PICC line was placed and her initial femoral line was removed.
Initially, the patient was covered broadly with cefipime, linezolid, and flagyl.
Once sensitivities became available, antibiotics were changed to cefipime/gent.
Stress dose steroids were started on admission and stopped on [**1-2**].
Plan is for cefipime and gentamicin to be continued for 10 more days to complete a 2 week course of both.
Patient had HD M-W-F.  Phos binders were held due to low phos.
Patient received epogen with dialysis.
5. h/o RLL PE (resulting in PEA arrest): Patient is on coumadin at home.
Coumadin was held for procedures (TEE, etc.)
She was on a heparin drip while off her coumadin.
INR should be checked after discharge and coumadin dose adjusted as needed.
Htn: Home metoprolol dose was held in the setting of sepsis.
It was not restarted prior to discharge as her BP remained low-normal without medication.
Glargine 8U hs continued.
Ascorbic Acid 500 mg PO BID  2.
Folic Acid 1 mg  3.
Zinc Sulfate 220 mg qd  4.
Acetaminophen 325 mg PO Q4-6H prn  5.
Ipratropium Bromide q4hrs  7.
Calcium Acetate 667 mg TIDWM  8.
Metoprolol 25 TID  10.
Insulin, GLargine 8U at HS  11.
Warfarin 2 mg qHS  12.
Linezolid 600 mg IV Q12H LD [**2159-12-27**] (PICC)   Discharge Medications: 1.
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Folic Acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q4-6H (every 4 to 6 hours) as needed for fever or pain.
Multivitamin     Capsule Sig: One (1) Cap PO DAILY (Daily).
Warfarin 2 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
Ipratropium Bromide 0.02 % Solution Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed.
Albuterol Sulfate 0.083 % Solution Sig: One (1) neb Inhalation Q6H (every 6 hours) as needed.
Insulin Glargine 100 unit/mL Solution Sig: Fifteen (15) units Subcutaneous at bedtime.
Insulin Regular Human 300 unit/3 mL Insulin Pen Sig: as directed  Subcutaneous four times a day: Please resume insulin sliding scale.
Gentamicin 40 mg/mL Solution Sig: Eighty (80) mg Injection dosed by level for 10 days: Please check a gentamicin level after each HD treatment and dose gentamicin for levels <2.
Cefepime 1 g Recon Soln Sig: One (1) gram Injection once a day for 10 days: Please give dose after HD on HD days.
Discharge Disposition: Extended Care  Facility: [**Hospital6 459**] for the Aged - LTC  Discharge Diagnosis: Primary Diagnoses: urosepsis with enterobacter and klebsiella in blood cultures, klebsiella and pseudomonas in urine end stage renal disease, on hemodialysis Secondary Diagnoses: history of PE hypertension CHF diabetes type II anemia, secondary to ESRD   Discharge Condition: stable   Discharge Instructions: 1.
Please take all medications as prescribed.
- antibiotics cefipime and gentamicin are to be continued fro 10 more days to complete a course of 2 weeks.
